Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Akin C, Jaffe ES, Raffeld M, Kirshenbaum AS, Daley T, Noel P et al. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. Am J Clin Pathol 2002; 118: 242–247.

    Article  CAS  PubMed  Google Scholar 

  2. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996; 12: 312–314.

    Article  CAS  PubMed  Google Scholar 

  3. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560–10564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Taylor ML, Sehgal D, Raffeld M, Obiakor H, Akin C, Mage RG et al. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. J Mol Diagn 2004; 6: 335–342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366–2372.

    Article  CAS  PubMed  Google Scholar 

  6. Valent P, Metcalfe DD, Horny H-P, Parwaresch RM, Li CY, Bennett JM et al. Mastocytosis. In: Jaffe ES, Harris N, Stein H & Vardiman JW (eds) Tumours of Hematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001, 292–302.

    Google Scholar 

  7. Nordstrom T, Ronaghi M, Forsberg L, de Faire U, Morgenstern R, Nyren P . Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing. Biotechnol Appl Biochem 2000; 31 (Pt 2): 107–112.

    Article  CAS  PubMed  Google Scholar 

  8. Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY et al. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 2006; 66: 473–481.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, W., Bueso-Ramos, C., Verstovsek, S. et al. Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease. Leukemia 21, 1574–1576 (2007). https://doi.org/10.1038/sj.leu.2404680

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404680

This article is cited by

Search

Quick links